Lipid mediators of liver injury in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of histopathological phenotypes ranging from simple steatosis to more severe liver disease associated with cell injury, including nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. Only a subset of patients with NAFLD...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology: Gastrointestinal and liver physiology Vol. 316; no. 1; pp. G75 - G81
Main Authors Liangpunsakul, Suthat, Chalasani, Naga
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.01.2019
SeriesLiver and Biliary Tract Physiology/Pathophysiology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of histopathological phenotypes ranging from simple steatosis to more severe liver disease associated with cell injury, including nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. Only a subset of patients with NAFLD develop NASH from yet incompletely understood mechanisms. Emerging data suggest lipid species other than triglycerides as contributors to the pathogenesis of NASH. In this mini review, we focus on the recent data on the mechanisms of NASH, focusing on these lipid mediators and their potential as therapeutic targets in NASH.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
S. Liangpunsakul and N. Chalasani contributed equally to this work.
ISSN:0193-1857
1522-1547
1522-1547
DOI:10.1152/ajpgi.00170.2018